A Test of the Effectiveness of a Device and Distraction for Pediatric Immunization Pain

Sponsor
MMJ Labs LLC (Industry)
Overall Status
Completed
CT.gov ID
NCT01152489
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
345
3
12

Study Details

Study Description

Brief Summary

The hypothesis of this study is that distraction cards used by the caretaker along with a vibrating cold pack placed proximal to the site of immunization will decrease the pain of routine pediatric immunizations when compared to a placebo device or standard care.

Condition or Disease Intervention/Treatment Phase
  • Device: Device: Buzzy
  • Device: Buzzy: sham device
Phase 2/Phase 3

Detailed Description

Needle pain is the most common and the most feared source of childhood pain, resulting in needle phobia for 10$ of adults. Current standard of care for immunizations in the US is no pain relief. An inexpensive, immediately effective form of needle pain control could reduce needle phobia or vaccine refusal in the long term if demonstrated to be effective for immunization pain.

Distraction can decrease procedural distress in children by 50%. The effect of using a multi-modal pain and distraction relieving approach has not been rigorously studied.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
345 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Phase II Study of the Effectiveness of a Device and Distraction for Pediatric Immunization Pain in Multiple Age Groups
Study Start Date :
Apr 1, 2010
Actual Primary Completion Date :
Apr 1, 2011
Actual Study Completion Date :
Apr 1, 2011

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Standard Care

Immunizations are given with standard care of no pain control

Active Comparator: Experimental

Vibrating device with cold pack held to arm proximal to injections within the same dermatome; caretakers offered and instructed in use of distraction cards.

Device: Device: Buzzy
"Buzzy", the vibrating cold pack, is held in place with a velcro strap or pressed by caretaker or nurse immediately prior and during immunizations. The vibration is activated and the device remains in place during the shot, moving locations if multiple shots are given. Distraction cards with pictures on one side and questions on the other are shown to the child while the caretaker asks the finding and seeking questions on the back.
Other Names:
  • Buzzy(R)
  • Flippits(TM)
  • Sham Comparator: Sham Device

    The device without batteries or cold pack held to arm proximal to injections. No formal distraction.

    Device: Buzzy: sham device
    The identical device without batteries or a cold pack is held in place proximal to the site with a velcro strap or pressed by parent or nurse immediately prior to immunizations. The device remains in place throughout the procedure, moving locations to complete multiple shots.
    Other Names:
  • Buzzy
  • Outcome Measures

    Primary Outcome Measures

    1. Pain of immunization [5 minutes during or immediately after immunizations]

      Infants' and toddlers' pain is assessed by coding videotapes using the FLACC (face, legs, activity, crying and consolability) scale. Patients age 4 and older rate pain using self-report via the Faces Pain Scale Revised.

    Secondary Outcome Measures

    1. Pain from immunization using observational measures [5 minutes immediately following immunization]

      Caretakers and nurses administering the shots rate pain using a 10cm Visual analog scale from "no pain" to "most pain possible"; duration of infant cry is also assessed following the procedure using coded videotape recordings.

    2. Treatment satisfaction [5 minutes after immunizations]

      10 item scale ranging from "strongly agree" to "strongly disagree" with ten parameters of satisfaction with the methods and concepts of immunization.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Months to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • children receiving routine immunizations
    Exclusion Criteria:
    • no caregiver present

    • chronic illness requiring frequent injections

    • clear cognitive impairments affecting communication

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • MMJ Labs LLC
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Investigators

    • Principal Investigator: Amy Baxter, MD, MMJ Labs LLC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01152489
    Other Study ID Numbers:
    • H09501
    • R44HD056647-01A2
    • NCT00910611
    First Posted:
    Jun 29, 2010
    Last Update Posted:
    Jun 22, 2011
    Last Verified:
    Jun 1, 2011
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 22, 2011